| Product NDC: | 49401-103 |
| Proprietary Name: | Raxibacumab |
| Non Proprietary Name: | raxibacumab |
| Active Ingredient(s): | 50 mg/mL & nbsp; raxibacumab |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 49401-103 |
| Labeler Name: | Human Genome Sciences, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | BLA125349 |
| Marketing Category: | BLA |
| Start Marketing Date: | 20121214 |
| Package NDC: | 49401-103-01 |
| Package Description: | 1 VIAL, SINGLE-USE in 1 CARTON (49401-103-01) > 34 mL in 1 VIAL, SINGLE-USE |
| NDC Code | 49401-103-01 |
| Proprietary Name | Raxibacumab |
| Package Description | 1 VIAL, SINGLE-USE in 1 CARTON (49401-103-01) > 34 mL in 1 VIAL, SINGLE-USE |
| Product NDC | 49401-103 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | raxibacumab |
| Dosage Form Name | INJECTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20121214 |
| Marketing Category Name | BLA |
| Labeler Name | Human Genome Sciences, Inc. |
| Substance Name | RAXIBACUMAB |
| Strength Number | 50 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes |